Blood Epigenetic Age may Predict Cancer Incidence and Mortality
View/ Open
Author
Zheng, Yinan
Joyce, Brian T.
Liu, Lei
Zhang, Wei
Dai, Qi
Shrubsole, Martha J.
Kibbe, Warren A.
Gao, Tao
Zhang, Zhou
Jafari, Nadereh
Vokonas, Pantel
Hou, Lifang
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1016/j.ebiom.2016.02.008Metadata
Show full item recordCitation
Zheng, Y., B. T. Joyce, E. Colicino, L. Liu, W. Zhang, Q. Dai, M. J. Shrubsole, et al. 2016. “Blood Epigenetic Age may Predict Cancer Incidence and Mortality.” EBioMedicine 5 (1): 68-73. doi:10.1016/j.ebiom.2016.02.008. http://dx.doi.org/10.1016/j.ebiom.2016.02.008.Abstract
Biological measures of aging are important for understanding the health of an aging population, with epigenetics particularly promising. Previous studies found that tumor tissue is epigenetically older than its donors are chronologically. We examined whether blood Δage (the discrepancy between epigenetic and chronological ages) can predict cancer incidence or mortality, thus assessing its potential as a cancer biomarker. In a prospective cohort, Δage and its rate of change over time were calculated in 834 blood leukocyte samples collected from 442 participants free of cancer at blood draw. About 3–5 years before cancer onset or death, Δage was associated with cancer risks in a dose-responsive manner (P = 0.02) and a one-year increase in Δage was associated with cancer incidence (HR: 1.06, 95% CI: 1.02–1.10) and mortality (HR: 1.17, 95% CI: 1.07–1.28). Participants with smaller Δage and decelerated epigenetic aging over time had the lowest risks of cancer incidence (P = 0.003) and mortality (P = 0.02). Δage was associated with cancer incidence in a ‘J-shaped’ manner for subjects examined pre-2003, and with cancer mortality in a time-varying manner. We conclude that blood epigenetic age may mirror epigenetic abnormalities related to cancer development, potentially serving as a minimally invasive biomarker for cancer early detection.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816845/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:26860290
Collections
- HMS Scholarly Articles [17917]
- SPH Scholarly Articles [6362]
Contact administrator regarding this item (to report mistakes or request changes)